| Dr Pamela Jo Grant, MD | |
|
830 Sw Lane St, Topeka, KS 66606-2487 | |
| (785) 354-5952 | |
| Not Available |
| Full Name | Dr Pamela Jo Grant |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 35 Years |
| Location | 830 Sw Lane St, Topeka, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174507214 | NPI | - | NPPES |
| 100179790B | Medicaid | KS | |
| 068002417 | Other | KS | MEDICARE PTAN |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cotton O'neil Clinic Revocable Trust | 5496659195 | 576 |
News Archive
Babatunde Osotimehin, executive director of the United Nations Population Fund (UNFPA) and under-secretary-general of the U.N., answers questions about his work from Forbes contributor Rahim Kanani in this interview excerpt.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that a Phase I study, called RV262, recently began to evaluate a combination DNA prime/MVA vector boost regimen that was developed to protect against diverse subtypes of HIV-1 prevalent in North America, Europe, Africa, and South America.
ALOKA CO., LTD., announced today its new ProSound Alpha 6, the next generation of compact color ultrasound systems. This new multi-purpose system, providing unprecedented performance in a variety of ultrasound applications, is fully upgradable and easy to use.
Ardea Biosciences, Inc. announced that it has completed formal End-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA) and successfully reached agreement on the following key aspects of its proposed lesinurad Phase 3 development plan: the overall size and design of the planned Phase 3 clinical studies, the primary endpoints, the total safety database proposed for NDA filing, manufacturing plans for both drug substance and drug product, the preclinical toxicology program and the clinical pharmacology program.
› Verified 9 days ago
| Entity Name | Cotton O'neil Clinic Revocable Trust |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811944457 PECOS PAC ID: 5496659195 Enrollment ID: O20031124000674 |
News Archive
Babatunde Osotimehin, executive director of the United Nations Population Fund (UNFPA) and under-secretary-general of the U.N., answers questions about his work from Forbes contributor Rahim Kanani in this interview excerpt.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that a Phase I study, called RV262, recently began to evaluate a combination DNA prime/MVA vector boost regimen that was developed to protect against diverse subtypes of HIV-1 prevalent in North America, Europe, Africa, and South America.
ALOKA CO., LTD., announced today its new ProSound Alpha 6, the next generation of compact color ultrasound systems. This new multi-purpose system, providing unprecedented performance in a variety of ultrasound applications, is fully upgradable and easy to use.
Ardea Biosciences, Inc. announced that it has completed formal End-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA) and successfully reached agreement on the following key aspects of its proposed lesinurad Phase 3 development plan: the overall size and design of the planned Phase 3 clinical studies, the primary endpoints, the total safety database proposed for NDA filing, manufacturing plans for both drug substance and drug product, the preclinical toxicology program and the clinical pharmacology program.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Pamela Jo Grant, MD 830 Sw Lane St, Topeka, KS 66606-2487 Ph: (785) 354-5952 | Dr Pamela Jo Grant, MD 830 Sw Lane St, Topeka, KS 66606-2487 Ph: (785) 354-5952 |
News Archive
Babatunde Osotimehin, executive director of the United Nations Population Fund (UNFPA) and under-secretary-general of the U.N., answers questions about his work from Forbes contributor Rahim Kanani in this interview excerpt.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that a Phase I study, called RV262, recently began to evaluate a combination DNA prime/MVA vector boost regimen that was developed to protect against diverse subtypes of HIV-1 prevalent in North America, Europe, Africa, and South America.
ALOKA CO., LTD., announced today its new ProSound Alpha 6, the next generation of compact color ultrasound systems. This new multi-purpose system, providing unprecedented performance in a variety of ultrasound applications, is fully upgradable and easy to use.
Ardea Biosciences, Inc. announced that it has completed formal End-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA) and successfully reached agreement on the following key aspects of its proposed lesinurad Phase 3 development plan: the overall size and design of the planned Phase 3 clinical studies, the primary endpoints, the total safety database proposed for NDA filing, manufacturing plans for both drug substance and drug product, the preclinical toxicology program and the clinical pharmacology program.
› Verified 9 days ago
Dr. Larry D Vande Garde, M. D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3461 Sw Macvicar Ave, Topeka, KS 66611 Phone: 785-267-1068 Fax: 785-267-1068 | |
Dr. Douglas S Gleason, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 800 Sw Lincoln St, Topeka, KS 66606 Phone: 785-233-5101 | |
Lisa A. Goularte, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3310 Se 29th St, #300, Topeka, KS 66605 Phone: 785-270-7444 | |
Josie Norris, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1412 Sw 6th Ave, Topeka, KS 66606 Phone: 785-232-6950 Fax: 785-232-4722 | |
Thomas M Wiley, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 634 Sw Mulvane St, Suite 209, Topeka, KS 66606 Phone: 785-295-5330 Fax: 785-295-5355 | |
Dr. Jamesina M Dickson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2830 Sw Urish Rd, Topeka, KS 66614 Phone: 785-273-4010 Fax: 785-233-1404 |